{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:42:21Z","timestamp":1784860941328,"version":"3.55.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"<jats:p>Psoriasis, an enduring systemic inflammatory dermatological condition with rising global incidence, presents significant impediments to conventional diagnostic and therapeutic strategies, primarily due to the reliance on subjective evaluation methods, notable adverse effects of treatments, and suboptimal long-term patient adherence. This narrative review systematically explores how digital innovations are transforming its comprehensive management. Digital innovations are transforming its comprehensive management: In diagnosis, artificial intelligence (AI)-integrated dermoscopy (EfficientNet-B4 model) achieves a 92.3% accuracy in differentiating psoriasis from other papulosquamous disorders, surpassing 230 dermatologists (86.7% accuracy) and enhancing severity assessment through deep learning, thereby mitigating subjective bias. In treatment, smart phototherapy devices refine dosage optimization through algorithmic processes, while AI-assisted biologic selection elevates complete clearance rates from 39% to 61% (compared to traditional protocols) with severe adverse events diminishing to less than 2%. In rehabilitation, Internet of things (IoT)-enabled monitoring systems assimilate real-time data through wearable technology and digital platforms to enhance self-management and adaptive intervention strategies. Multi-omics data integration and computational drug design expedite the development of novel therapies. Nevertheless, challenges such as inadequate data standardization, privacy issues, restricted algorithmic transparency, and lack of prolonged validation remain. Digital technologies are reconfiguring psoriasis management from diagnosis (objective imaging) to treatment (personalized dose management) and rehabilitation (IoT-enabled monitoring), establishing a precision-based, data-centric framework.<\/jats:p>","DOI":"10.3389\/fdgth.2025.1656585","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:48:20Z","timestamp":1762778900000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Digital technologies in psoriasis management: from precision diagnosis to therapeutic innovation and holistic care"],"prefix":"10.3389","volume":"7","author":[{"given":"Zhenni","family":"Gong","sequence":"first","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Shihezi University","place":["Shihezi, China"]},{"name":"Shihezi University Medical College","place":["Shihezi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Shihezi University","place":["Shihezi, China"]},{"name":"Shihezi University Medical College","place":["Shihezi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Shihezi University","place":["Shihezi, China"]},{"name":"Shihezi University Medical College","place":["Shihezi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shihezi University Medical College","place":["Shihezi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Cheng","sequence":"additional","affiliation":[{"name":"Shihezi University Medical College","place":["Shihezi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[{"name":"Community Health Service Center of the Urban Area of Shihezi City","place":["Shihezi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Shihezi University","place":["Shihezi, China"]},{"name":"Shihezi University Medical College","place":["Shihezi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Shihezi University","place":["Shihezi, China"]},{"name":"Shihezi University Medical College","place":["Shihezi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"122591","DOI":"10.1016\/j.ijpharm.2023.122591","article-title":"Microneedles as a momentous platform for psoriasis therapy and diagnosis: a state-of-the-art review","volume":"632","author":"Gowda","year":"2023","journal-title":"Int J Pharm"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/s0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-621","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/ddg.14507","article-title":"German S3-guideline on the treatment of psoriasis vulgaris, adapted from EuroGuiDerm\u2014part 2: treatment monitoring and specific clinical or comorbid situations","volume":"19","author":"Nast","year":"2021","journal-title":"J der Deutschen Dermatologischen Gesellschaft"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/jdv.14960","article-title":"Intra- and interobserver variability of image-based PASI assessments in 120 patients suffering from plaque-type psoriasis","volume":"32","author":"Fink","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41419-024-06514-y","article-title":"Saracatinib inhibits necroptosis and ameliorates psoriatic inflammation by targeting MLKL","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1038\/s41598-024-54447-5","article-title":"Reduced economic disparity in biologics use for psoriasis after introducing the reducing copayment program","volume":"14","author":"Jung","year":"2024","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s40257-024-00883-y","article-title":"Image-Based artificial intelligence in psoriasis assessment: the beginning of a new diagnostic era?","volume":"25","author":"Goessinger","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100611","DOI":"10.1016\/j.pacs.2024.100611","article-title":"Structural and functional imaging of psoriasis for severity assessment and quantitative monitoring of treatment response using high-resolution optoacoustic imaging","volume":"38","author":"Li","year":"2024","journal-title":"Photoacoustics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40580-024-00424-7","article-title":"Microfluidics for disease diagnostics based on surface-enhanced Raman scattering detection","volume":"11","author":"Yu","year":"2024","journal-title":"Nano Convergence"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1039\/d0lc00506a","article-title":"Critical review: digital resolution biomolecular sensing for diagnostics and life science research","volume":"20","author":"Huang","year":"2020","journal-title":"Lab Chip"},{"key":"B12","doi-asserted-by":"publisher","first-page":"109754","DOI":"10.1016\/j.cie.2023.109754","article-title":"Diagnostic clinical decision support based on deep learning and knowledge-based systems for psoriasis: from diagnosis to treatment options","volume":"187","author":"Mohammad","year":"2024","journal-title":"Comp Indust Eng"},{"key":"B13","doi-asserted-by":"publisher","first-page":"100513","DOI":"10.1016\/j.pacs.2023.100513","article-title":"Raster-scanning optoacoustic mesoscopy biomarkers for atopic dermatitis skin lesions","volume":"31","author":"Nau","year":"2023","journal-title":"Photoacoustics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"104924","DOI":"10.1016\/j.compbiomed.2021.104924","article-title":"A convolutional neural network trained with dermoscopic images of psoriasis performed on par with 230 dermatologists","volume":"139","author":"Yang","year":"2021","journal-title":"Comput Biol Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"eabm8059","DOI":"10.1126\/scitranslmed.abm8059","article-title":"Enabling precision monitoring of psoriasis treatment by optoacoustic mesoscopy","volume":"14","author":"Hindelang","year":"2022","journal-title":"Sci Transl Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1016\/j.jid.2025.03.034","article-title":"Enhancing diagnosis of psoriasis and inflammatory skin diseases: a spatially aligned multimodal model integrating clinical and dermoscopic images","volume":"145","author":"Wang","year":"2025","journal-title":"J Invest Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e44932","DOI":"10.2196\/44932","article-title":"Artificial intelligence\u2013based psoriasis severity assessment: real-world study and application","volume":"25","author":"Huang","year":"2023","journal-title":"J Med Internet Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3390\/cells12111541","article-title":"Metronomic photodynamic therapy with conjugated polymer nanoparticles in glioblastoma tumor microenvironment","volume":"12","author":"Caverz\u00e1n","year":"2023","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/jdv.20527","article-title":"Impact of light dose and fluence rate on the efficacy and tolerability of topical 5-ALA photodynamic therapy for actinic keratoses: a randomized, controlled, observer-blinded intrapatient comparison study","volume":"39","author":"Tanew","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/ddg.15665","article-title":"Combination of LED illumination and daylight photodynamic therapy for the treatment of actinic keratosis in solid organ transplant recipients: a prospective, randomized, comparative, intra-patient study","volume":"23","author":"Oteiza-Rius","year":"2025","journal-title":"J Dtsch Dermatol Ges"},{"key":"B21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2025.02.063","article-title":"Characterization and treatment outcomes of biologic therapy in super-responders and biologic-refractory psoriasis patients: a single-center retrospective study in China","volume":"93","author":"Liu","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/bjd\/ljae147","article-title":"Insulin resistance impairs biologic agent response in moderate-to-severe plaque psoriasis: insights from a prospective cohort study in China","volume":"191","author":"Huang","year":"2024","journal-title":"Br J Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12967-023-04847-4","article-title":"A novel online calculator based on clinical features and hematological parameters to predict total skin clearance in patients with moderate to severe psoriasis","volume":"22","author":"Jiang","year":"2024","journal-title":"J Transl Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40259-022-00522-0","article-title":"Impact of obesity on response to biologic therapies in patients with inflammatory bowel diseases","volume":"36","author":"Bassi","year":"2022","journal-title":"BioDrugs"},{"key":"B25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12967-025-06371-z","article-title":"From virtual to reality: innovative practices of digital twins in tumor therapy","volume":"23","author":"Shen","year":"2025","journal-title":"J Transl Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/bjd.20482","article-title":"Patient preferences for stratified medicine in psoriasis: a discrete choice experiment","volume":"185","author":"Dalal","year":"2021","journal-title":"Br J Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40257-021-00603-w","article-title":"Biologic treatment algorithms for moderate-to-severe psoriasis with comorbid conditions and special populations: a review","volume":"22","author":"Thatiparthi","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/bjd.20140","article-title":"Defining trajectories of response in patients with psoriasis treated with biologic therapies","volume":"185","author":"Geifman","year":"2021","journal-title":"Br J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jaad.2020.09.047","article-title":"Tildrakizumab efficacy, drug survival, and safety are comparable in patients with psoriasis with and without metabolic syndrome: long-term results from 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)","volume":"84","author":"Lebwohl","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s40257-023-00801-8","article-title":"Do biologic treatments for psoriasis lower the risk of psoriatic arthritis? A systematic review","volume":"24","author":"Aronovich","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s40257-020-00533-z","article-title":"Progress to date in advancing stratified medicine in psoriasis","volume":"21","author":"Reid","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/art.41946","article-title":"Incidence of psoriatic arthritis among patients receiving biologic treatments for psoriasis: a nested case-control study","volume":"74","author":"Rosenthal","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/jamadermatol.2022.3171","article-title":"Multivariable predictive models to identify the optimal biologic therapy for treatment of patients with psoriasis at the individual level","volume":"158","author":"Nielsen","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1080\/17460441.2023.2246880","article-title":"The preclinical discovery and development of deucravacitinib for the treatment of psoriasis","volume":"18","author":"Coscarella","year":"2023","journal-title":"Expert Opin Drug Discov"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e12778","DOI":"10.1111\/bjhp.12778","article-title":"A qualitative exploration of the prospective acceptability of the MiDerm app; a complex digital intervention for adults living with skin conditions","volume":"30","author":"Hewitt","year":"2025","journal-title":"Br J Health Psychol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.fmre.2021.08.020","article-title":"Establishment and validation of psoriasis evaluation models","volume":"2","author":"Hu","year":"2022","journal-title":"Fundam Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e28149","DOI":"10.2196\/28149","article-title":"Impact of an eHealth smartphone app on the mental health of patients with psoriasis: prospective randomized controlled intervention study","volume":"9","author":"Domogalla","year":"2021","journal-title":"JMIR Mhealth Uhealth"},{"key":"B38","first-page":"e34017","article-title":"German Mobile apps for patients with psoriasis: systematic search and evaluation","volume-title":"JMIR Mhealth Uhealth","author":"Lull","year":"2022"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8790","DOI":"10.1039\/d4cs00286e","article-title":"Fibres-threads of intelligence-enable a new generation of wearable systems","volume":"53","author":"Dang","year":"2024","journal-title":"Chem Soc Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e004699","DOI":"10.1136\/rmdopen-2024-004699","article-title":"Digital biomarkers for psoriatic arthritis: a qualitative focus group study on patient-perceived opportunities and barriers","volume":"10","author":"de Groot","year":"2024","journal-title":"RMD Open"},{"key":"B41","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41746-024-01220-7","article-title":"Digital twins in dermatology, current status, and the road ahead","volume":"7","author":"Akbarialiabad","year":"2024","journal-title":"NPJ Digit Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2519\/jospt.2023.12000","article-title":"Pros and cons of using artificial intelligence chatbots for musculoskeletal rehabilitation management","volume":"53","author":"Rossettini","year":"2023","journal-title":"J Orthop Sports Phys Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e57823","DOI":"10.2196\/57823","article-title":"Digital Media usage behavior and its impact on the physician-patient relationship: cross-sectional study among individuals affected by psoriasis in Germany","volume":"26","author":"Erbas","year":"2024","journal-title":"J Med Internet Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/ddg.15585","article-title":"Impact of a dermatological rehabilitation program on cardiovascular risks of psoriasis patients","volume":"23","author":"Attar","year":"2025","journal-title":"J Dtsch Dermatol Ges"},{"key":"B45","doi-asserted-by":"publisher","first-page":"847312","DOI":"10.3389\/fimmu.2022.847312","article-title":"Harnessing big data, smart and digital technologies and artificial intelligence for preventing, early intercepting, managing, and treating psoriatic arthritis: insights from a systematic review of the literature","author":"Bragazzi","year":"2022","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1080\/10717544.2020.1754527","article-title":"Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis","volume":"27","author":"Fereig","year":"2020","journal-title":"Drug Deliv"},{"key":"B47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.semcancer.2020.09.006","article-title":"Innovative trial design in precision oncology","volume":"84","author":"Tsimberidou","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jid.2023.01.021","article-title":"Atopic polygenic risk score is associated with paradoxical eczema developing in patients with psoriasis treated with biologics","volume":"143","author":"Al-Janabi","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"107051","DOI":"10.1016\/j.compbiomed.2023.107051","article-title":"Perspective of artificial intelligence in healthcare data management: a journey towards precision medicine","volume":"162","author":"Gupta","year":"2023","journal-title":"Comput Biol Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5634","DOI":"10.1109\/jbhi.2023.3299028","article-title":"Digital twin in healthcare: a study for chronic wound management","volume":"27","author":"Sarp","year":"2023","journal-title":"IEEE J Biomed Health Inform"},{"key":"B51","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/ddg.15033","article-title":"Current developments and perspectives in psoriasis","volume":"21","author":"Schon","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"key":"B52","doi-asserted-by":"publisher","first-page":"102916","DOI":"10.1016\/j.jaut.2022.102916","article-title":"Pathogenesis, multi-omics research, and clinical treatment of psoriasis","volume":"133","author":"Yu","year":"2022","journal-title":"J Autoimmun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.jid.2022.01.014","article-title":"From empirical to pathogenesis-based treatments for psoriasis","volume":"142","author":"van de Kerkhof","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1374763","DOI":"10.3389\/fimmu.2024.1374763","article-title":"Single-cell sequencing analysis and multiple machine-learning models revealed the cellular crosstalk of dendritic cells and identified FABP5 and KLRB1 as novel biomarkers for psoriasis","volume":"15","author":"Ma","year":"2024","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/antiox13101222","article-title":"Unraveling mitochondrial reactive oxygen Species involvement in psoriasis: the promise of antioxidant therapies","volume":"13","author":"Ahmad Jamil","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1097\/cm9.0000000000002504","article-title":"Research progress of metabolomics in psoriasis","volume":"136","author":"Guo","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/bjd\/ljad332","article-title":"Retrospective pharmacogenetic study of psoriasis highlights the role of KLK7 in tumour necrosis factor signalling","volume":"190","author":"Zhang","year":"2023","journal-title":"Br J Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"115480","DOI":"10.1016\/j.addr.2024.115480","article-title":"Biopharmaceutical drug delivery and phototherapy using protein crystals","volume":"216","author":"Zhou","year":"2025","journal-title":"Adv Drug Deliv Rev"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1001\/jamadermatol.2024.3897","article-title":"Home- vs office-based narrowband UV-B phototherapy for patients with psoriasis: the LITE randomized clinical trial","volume":"160","author":"Gelfand","year":"2024","journal-title":"JAMA Dermatol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"125385","DOI":"10.1016\/j.ijpharm.2025.125385","article-title":"A new era of psoriasis treatment: drug repurposing through the lens of nanotechnology and machine learning","volume":"673","author":"Tarek","year":"2025","journal-title":"Int J Pharm"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1390589","DOI":"10.3389\/fimmu.2024.1390589","article-title":"Alpha-Pinene-encapsulated lipid nanoparticles diminished inflammatory responses in THP-1 cells and imiquimod-induced psoriasis-like skin injury and splenomegaly in mice","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"104208","DOI":"10.1016\/j.drudis.2024.104208","article-title":"Advances in, and prospects of, 3D preclinical models for skin drug discovery","volume":"29","author":"Imran","year":"2024","journal-title":"Drug Discov Today"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1111\/jdv.18178","article-title":"Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021-a two-round delphi survey among international experts","volume":"36","author":"Ziehfreund","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jdv.16691","article-title":"Tolerance and efficacy of a new celastrol-containing balm as adjunct care in psoriasis","volume":"34","author":"Thouvenin","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40257-021-00649-w","article-title":"New topical therapies for psoriasis","volume":"23","author":"Le","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11926-020-00958-9","article-title":"Aiming for cure and preventive initiatives in psoriatic disease: building synergy at NPF, GRAPPA, and PPACMAN","volume":"22","author":"Bell","year":"2020","journal-title":"Curr Rheumatol Rep"}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2025.1656585\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:31:23Z","timestamp":1772627483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2025.1656585\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":66,"alternative-id":["10.3389\/fdgth.2025.1656585"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2025.1656585","relation":{},"ISSN":["2673-253X"],"issn-type":[{"value":"2673-253X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"article-number":"1656585"}}